Renal Business Today - Cardioavscular Disease (CVD)

WASHINGTON— Two seemingly similar blood pressure-lowering drugs have different effects on the heart health of dialysis patients, according to a study published online in the Journal of the American Society Nephrology (JASN). ...More

December 8, 2011

Posted in News, Clinical & Pharma

FDA Recommends Vytorin Approval in CKD Patients

WHITEHOUSE STATION, N.J.— Merck announced Nov. 2 that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's Vytorin for use in patients with pre-dialysis chronic kidney ...More

November 2, 2011

Posted in News

Mild CKD in Kids Causes Poor Growth, Heart Problems

WASHINGTON—Children with only mildly to moderately impaired kidney function experience poor growth, delays in puberty, and heart problems, according to a study published online in the Clinical Journal of the American Society Nephrology (CJASN). ...More

August 15, 2011

Posted in News, Clinical & Pharma

Biomarkers Show Death Risk in Elderly with Heart Failure Symptoms

LINKOPING, Sweden—Elderly patients with symptoms of heart failure and increased concentrations in the blood of the biomarker copeptin, or a combination of elevated concentrations of copeptin and the biomarker NT-proBNP, had an associated increased risk of all-cause death, ...More

May 25, 2011

Posted in News, Clinical & Pharma

Follow-Up Rehab Boosts Survival for Angioplasty Patients

DALLAS—Patients who undergo a procedure to unblock a coronary artery are more likely to survive longer if they participate in structured follow-up care, according to research in Circulation: Journal of the American Heart Association. ...More

May 18, 2011

Posted in News, Clinical & Pharma

Study Reveals Concerns Over EPO in Heart Attack Patients

CHICAGO—Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open ...More

May 13, 2011

Posted in News, Clinical & Pharma

Women Face Higher Risk of Kidney Damage After Heart Imaging Test

DETROIT—Women are at higher risk than men of developing kidney damage after undergoing a coronary angiogram, according to a Henry Ford Hospital study. ...More

April 27, 2011

Posted in News, Clinical & Pharma

Physical Activity Decreases Salt's Effect on Blood Pressure

ATLANTA—More physical activity can reduce the affect a high-salt diet has on high blood pressure, according to a study to be presented March 30 at the American Heart Association's meeting on nutrition, physical activity, and cardiovascular disease. ...More

March 28, 2011

Posted in News, Clinical & Pharma

Weak Link Between Certain Biomarkers, Cardiovascular Risks in CKD

CHICAGO—Even though clinical practice guidelines for patients with chronic kidney disease recommend specific treatment target levels for serum phosphorus, parathyroid hormone, and calcium to reduce the risk of cardiovascular events, an analysis of data from previous studies ...More

March 16, 2011

Posted in News, Clinical & Pharma

Nile Therapeutics, Medtronic Working on Renal Drug

SAN MATEO, Calif.—Nile Therapeutics and Medtronic are collaborating on the clinical development of Nile’s proprietary natriuretic peptide, cenderitide (formerly CD-NP), for heart failure and renal disease applications. ...More

March 1, 2011

Posted in News, Clinical & Pharma

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Cardioavscular Disease (CVD)

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail